Cargando…
Thromboprophylaxis with argatroban in critically ill patients with sepsis: a review
During sepsis, an initial prothrombotic shift takes place, in which coagulatory acute-phase proteins are increased, while anticoagulatory factors and platelet count decrease. Further on, the fibrinolytic system becomes impaired, which contributes to disease severity. At a later stage in sepsis, coag...
Autores principales: | Bachler, Mirjam, Asmis, Lars M., Koscielny, Jürgen, Lang, Thomas, Nowak, Hartmuth, Paulus, Patrick, Schewe, Jens-Christian, von Heymann, Christian, Fries, Dietmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9470048/ https://www.ncbi.nlm.nih.gov/pubmed/35703225 http://dx.doi.org/10.1097/MBC.0000000000001133 |
Ejemplares similares
-
A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra(®)) in Critically Ill Patients with Heparin Resistance †
por: Bachler, Mirjam, et al.
Publicado: (2020) -
Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis
por: Kim, Se-Chan, et al.
Publicado: (2015) -
In vitro
Effect of Dalteparin and Argatroban on Hemostasis in Critically Ill Sepsis Patients with New-Onset Thrombocytopenia
por: Nygaard, Søren, et al.
Publicado: (2023) -
Progression of Fibrinogen Decrease during High Dose Tigecycline Therapy in Critically Ill Patients: A Retrospective Analysis
por: Treml, Benedikt, et al.
Publicado: (2021) -
Reversible Crystallization of Argatroban after Subcutaneous Application in Pigs
por: Lopez, Mercedes, et al.
Publicado: (2012)